CClinicalTrials.gg
CompletedNCT06156852Updated Dec 5, 2023

Comparing the Effects of Mindfulness-Based and Cognitive Behavioral-Based Stress Reduction in Medical Students

An interventional study of Mindfulness-based stress reduction group and Cognitive behavioral-based stress reduction group in Stress, Anxiety and Depressive Symptoms, sponsored by Gazi University. Completed at 1 site in Turkey. Per ClinicalTrials.gov, last updated 2023-12-05.

Sponsored by Gazi University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Apr 2022, registered Nov 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
253
Allocation
Randomized
Sex
All
01

Study summary

We aimed to compare the effects of the Mindfulness-Based Stress Reduction (MBSR) and the Cognitive Behavioural Stress Reduction (CBSR) group interventions on depression and anxiety symptoms and perceived stress of medical students.

323 medical students applied to participate in one of the group interventions and were assessed with the Mini International Neuropsychiatric Interview. Of these, 253 (77% female, mean age=21.9 ± 2.9 years) were allocated into online MBSR (n=127) and online CBSR (n=126) groups after randomization. Their anxiety and depressive symptoms and perceived stress levels were assessed at baseline and after 8 weeks of interventions.

Read the detailed description

Objective: Medical students face an enormous amount of stress. They suffer from higher rates of depression, anxiety, and suicide compared to the general population. Despite experiencing more mental health problems, there is a lack of research exploring ways to improve their mental health. Although there are a few small sample studies investigating the effectiveness of Mindfulness-Based Stress Reduction (MBSR) on medical students, there is no study comparing its effectiveness against an active intervention group in the literature.

Aim: We aimed to compare the effects of the Mindfulness-Based Stress Reduction (MBSR) and the Cognitive Behavioural Stress Reduction (CBSR) group interventions on depression and anxiety symptoms and the perceived stress level of medical students.

Methods: The medical students who studied in medical faculties in Ankara/Turkey were asked to participate in our study. In order to invite students to the study, posters announcing our study were put on the boards of the lecture halls of medical faculties, and our posters were shared on social media platforms where these students were involved. After receiving applications from a sufficient number of students who volunteered to participate in the study, the students were assessed online with Mini International Neuropsychiatric Interview by a senior psychiatry resident. Medical students who were eligible to take part in the study were asked to fill out the forms (sociodemographic data form) and scales (Hospital Anxiety-Depression Scale, Perceived Stress Scale) within one week before being allocated into groups. After the students were randomized into two groups with the help of a computer program, stress reduction interventions were conducted for 8 weeks in groups of 10-12 students. After enough participants volunteered to participate in the study, the participants were recruited mainly in two groups and randomized as they were recruited. The first group consisted of 157 participants and the second group consisted of 96 participants. When the group interventions were completed at the end of 8 weeks, the participants were asked to complete the scales (Hospital Anxiety-Depression Scale, Perceived Stress Scale) within one week.

Inclusion Criteria:

  • Being a medical student at a university in Ankara
  • Being older than 18 years old
  • Not having participated in mindfulness-based or cognitive behavioral stress reduction groups or individual therapies
  • Volunteering to participate in the study

Exclusion Criteria:

  • Having known mindfulness-based stress reduction methods and applied them in their lives
  • Having known cognitive behavioral stress reduction methods and applied them in their lives
  • Depression and mania severe enough to prevent their participation in the study
  • High risk of suicide
  • Having a chronic physical condition that may prevent participation in the study
  • History of psychotic disorder and/or meeting the diagnosis of psychotic disorder at the assessment stage

Cognitive Behavioral-Based Stress Reduction Groups Stress-coping groups based on cognitive behavioral methods were implemented by adapting them to medical faculty students. The whole intervention was done using the "Zoom" application on the online platform for 8 weeks. Each group meeting was 90 minutes long and held on a specific day and time of the week (19.00-20.30) previously determined by the group members. The groups were planned to consist of 10-12 people and no new members were included after the group started in order not to compromise the integrity of the group.

Mindfulness-Based Stress Reduction Groups Mindfulness-based stress reduction groups consist of structured 8-week 2-hour long group meetings and a 4-hour silence day. Along with mindfulness practices, stress, stress management and use of mindfulness-based practices in daily life and interpersonal communication are the subjects that are being worked on during the sessions. Each group meeting was 120 minutes long and held on a specific day and time of the week (20.00-22.00) previously determined by the group members. The groups were planned to consist of 10-12 people and no new members were included after the group started in order not to compromise the integrity of the group.

Statistical Methods:

SPSS 29 was used for all statistical analysis. In our study, both intention-to-treat (ITT) analysis and per-protocol (PP) analysis were used to assess outcomes. In the ITT analysis, we used multiple imputation to address missing values. All assessments and group interventions were done online. In PP analysis, those who attended five or more sessions were considered to have completed the study. By using two methods and comparing the results of these analyses with each other, we aimed to obtain the most realistic results.

Assessment features-->Statistical methods

Determination of the sample size-->Power analysis(G*power)

Determining the suitability of the data for normal distribution-->Kolmogorov Smirnov / Shapiro-Wilks test Skewness and kurtosis (-1.5- +1.5) Q-Q plot (linearity analysis)

Analyzing the demographic data of the participants-->Percentage distribution, Frequency distribution

Comparison of demographic data of the participants in the two groups-->Chi-square, Independent sample t-test

Comparison of the pre-test and post-test results of the participants in the two groups for each group-->Dependent sample t-test, Mann Whitney U test

Comparison of the change between pre-test and post-test between two groups -->Independent sample t-test, Wilcoxon signed-rank test

Investigate patterns of missingness and assignment of missing data-->Little's test Multiple imputation*

02

Conditions studied

  • Stress
  • Anxiety
  • Depressive Symptoms

Browse trials for

03

In context

Depression

8,059 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's enrollment of 253 is above the median of 84 across 6,722 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Gazi University is the lead sponsor of 532 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being a medical student at a university in Ankara
  • Being older than 18 years old
  • Not having participated in mindfulness-based or cognitive behavioral stress reduction groups or individual therapies
  • Volunteering to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having known mindfulness-based stress reduction methods and applied them in their lives
  • Having known cognitive behavioral stress reduction methods and applied them in their lives
  • Depression and mania severe enough to prevent their participation in the study
  • High risk of suicide
  • Having a chronic physical condition that may prevent participation in the study
  • History of psychotic disorder and/or meeting the diagnosis of psychotic disorder at the assessment stage
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
253 participants (actual)

Study arms

  • Active comparator
    Mindfulness-based stress reduction group (MBSR)

    Medical faculty students who volunteered to participate in the study were assessed by a senior psychiatry resident. The students who were found to be eligible to take part in the study were randomized to two groups (MBSR and CBSR groups).

    Other: Mindfulness-based stress reduction group

  • Active comparator
    Cognitive behavioral based stress reduction group (CBSR)

    Medical faculty students who volunteered to participate in the study were assessed by a senior psychiatry resident. The students who were found to be eligible to take part in the study were randomized to two groups (MBSR and CBSR groups).

    Other: Cognitive behavioral-based stress reduction group

Interventions

  • OtherMindfulness-based stress reduction group

    Mindfulness-based stress reduction (MBSR) group interventions were implemented for eight weeks.

  • OtherCognitive behavioral-based stress reduction group

    Cognitive behavioral-based stress reduction group interventions were implemented for eight weeks.

06

What researchers measure

Primary outcomes

  1. Perceived stress level

    Perceived stress levels were assessed with the Perceived Stress Scale (PSS). This is a widely used scale to assess the effects of different situations on our emotions and perceived stress.

    Time frame: 8 weeks

  2. Anxiety level

    Anxiety symptom levels were assessed with the Hospital anxiety and depression scale (HADS). This scale is a self-assessment scale developed to determine the risk of anxiety and depression in patients with physical illness and primary health care patients and to measure their level and change in severity.

    Time frame: 8 weeks

  3. Depressive symptom level

    Depressive symptom levels were assessed with the Hospital anxiety and depression scale (HADS). This scale is a self-assessment scale developed to determine the risk of anxiety and depression in patients with physical illness and primary health care patients and to measure their level and change in severity.

    Time frame: 8 weeks

07

Study locations

1 site
  • Ayşegül Yay Pençe
    Ankara, 06560, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06156852
Lead sponsor
Gazi University
Responsible party
Aysegul Yay (Research assistant, Gazi University) — Principal investigator
First posted
Dec 5, 2023
Start date
Apr 1, 2022
Primary completion
Dec 30, 2022
Completion
Jun 15, 2023
Last update
Dec 5, 2023

Study contacts

Selçuk Aslan, MD
study director · Gazi University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion